The Budget Blindside: Did Pharma Fight The Wrong Battle?
Executive Summary
The bigger 'Donut Hole' discount is a rare loss for pharma on Capitol Hill – one that may in part be because industry did too good a job fighting off a different drug pricing measure.
You may also be interested in...
Generics, Budgeting, And The Stubborn Persistence Of Cost Savings
ANDA sponsors want inflation penalty in Medicaid repealed, but long struggle to eliminate IPAB shows just how hard it may be for generics industry to get that 'fix'.
A New Start: President Biden Visits Pfizer
President Biden’s relationship with the US pharmaceutical industry is starting out with the starkest contrast imaginable with the initial approach of the Trump Administration – at least on the symbolic level.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: